Real-time enrollment status for this based on the limited information provided, i cannot determine the primary patient-facing medical condition from this clinical trial data. the study title only mentions it's evaluating the safety of pirtobrutinib, and the conditions section only lists "drug:pirtobrutinib" which is not a medical condition. without additional context about what condition this drug treats, i cannot provide the requested output. clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT06876649 |
| Recruiting Status | Recruiting |
| Condition | Based on the limited information provided, I cannot determine the primary patient-facing medical condition from this clinical trial data. The study title only mentions it's evaluating the safety of Pirtobrutinib, and the conditions section only lists "DRUG:Pirtobrutinib" which is not a medical condition. Without additional context about what condition this drug treats, I cannot provide the requested output. |
| Phase | Clinical Trial |
| Target Enrollment | 787 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | January 21, 2026 (Jan 21, 2026) |
As of March 2, 2026: Clinical trial NCT06876649 is currently recruiting participants. This clinical trial study for based on the limited information provided, i cannot determine the primary patient-facing medical condition from this clinical trial data. the study title only mentions it's evaluating the safety of pirtobrutinib, and the conditions section only lists "drug:pirtobrutinib" which is not a medical condition. without additional context about what condition this drug treats, i cannot provide the requested output. is actively seeking new participants at 18 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06876649 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06876649 was last updated Jan 21, 2026 (January 21, 2026). HelloStudys verifies this status automatically.